» Articles » PMID: 18790854

Bupivacaine Blocks N-type Inactivating Kv Channels in the Open State: No Allosteric Effect on Inactivation Kinetics

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2008 Sep 16
PMID 18790854
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Local anesthetics bind to ion channels in a state-dependent manner. For noninactivating voltage-gated K channels the binding mainly occurs in the open state, while for voltage-gated inactivating Na channels it is assumed to occur mainly in inactivated states, leading to an allosterically caused increase in the inactivation probability, reflected in a negative shift of the steady-state inactivation curve, prolonged recovery from inactivation, and a frequency-dependent block. How local anesthetics bind to N-type inactivating K channels is less explored. In this study, we have compared bupivacaine effects on inactivating (Shaker and K(v)3.4) and noninactivating (Shaker-IR and K(v)3.2) channels, expressed in Xenopus oocytes. Bupivacaine was found to block these channels time-dependently without shifting the steady-state inactivation curve markedly, without a prolonged recovery from inactivation, and without a frequency-dependent block. An analysis, including computational testing of kinetic models, suggests binding to the channel mainly in the open state, with affinities close to those estimated for corresponding noninactivating channels (300 and 280 microM for Shaker and Shaker-IR, and 60 and 90 microM for K(v)3.4 and K(v)3.2). The similar magnitudes of K(d), as well as of blocking and unblocking rate constants for inactivating and noninactivating Shaker channels, most likely exclude allosteric interactions between the inactivation mechanism and the binding site. The relevance of these results for understanding the action of local anesthetics on Na channels is discussed.

Citing Articles

Closed and open state dependent block of potassium channels cause opposing effects on excitability - a computational approach.

Agren R, Nilsson J, Arhem P Sci Rep. 2019; 9(1):8175.

PMID: 31160624 PMC: 6546692. DOI: 10.1038/s41598-019-44564-x.


The Importance of the Dissociation Rate in Ion Channel Blocking.

Zeberg H, Nilsson J, Arhem P Front Cell Neurosci. 2018; 12:33.

PMID: 29479308 PMC: 5811512. DOI: 10.3389/fncel.2018.00033.


Bupivacaine inhibits large conductance, voltage- and Ca2+- activated K+ channels in human umbilical artery smooth muscle cells.

Martin P, Enrique N, Palomo A, Rebolledo A, Milesi V Channels (Austin). 2012; 6(3):174-80.

PMID: 22688134 PMC: 3431591. DOI: 10.4161/chan.20362.

References
1.
Kamb A, Iverson L, Tanouye M . Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel. Cell. 1987; 50(3):405-13. DOI: 10.1016/0092-8674(87)90494-6. View

2.
Grant A, Chandra R, Keller C, Carboni M, Starmer C . Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells. Biophys J. 2000; 79(6):3019-35. PMC: 1301180. DOI: 10.1016/S0006-3495(00)76538-6. View

3.
Visan V, Fajloun Z, Sabatier J, Grissmer S . Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels. Mol Pharmacol. 2004; 66(5):1103-12. DOI: 10.1124/mol.104.002774. View

4.
Starmer C, Grant A, Strauss H . Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J. 1984; 46(1):15-27. PMC: 1434933. DOI: 10.1016/S0006-3495(84)83994-6. View

5.
Nilsson J, Elinder F, Arhem P . Mechanisms of bupivacaine action on Na+ and K+ channels in myelinated axons of Xenopus laevis. Eur J Pharmacol. 1998; 360(1):21-9. DOI: 10.1016/s0014-2999(98)00631-1. View